Labetalol Tillomed

Labetalol Hydrochloride, the active ingredient in Labetalol Tillomed, is a beta blocker (mixed alpha‑1 and non‑selective beta‑adrenergic antagonist) presented as an oral dosage form for oral use. It is employed to lower blood pressure in patients with hypertension and to manage hypertensive emergencies. GNH USA supplies Labetalol Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Labetalol Tillomed is a mixed‑alpha and beta‑adrenergic blocker used in cardiovascular conditions.

Hypertension: reduces systemic blood pressure for long‑term control. Hypertensive emergencies: provides rapid blood pressure reduction in acute crises. Post‑operative hypertension: helps stabilize blood pressure after surgical procedures.

Labetalol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Fatigue or weakness - Headache - Nausea or abdominal discomfort - Nasal congestion - Tremor

Serious or Rare Side Effects: - Severe bradycardia or heart block - Acute heart failure - Hepatic dysfunction - Bronchospasm in asthmatic patients - Hypotension leading to syncope

Before prescribing Labetalol, clinicians should consider several safety measures.

Assess cardiovascular status: evaluate for existing heart block or severe bradycardia. Monitor liver function: avoid in patients with significant hepatic impairment. Review asthma history: beta‑blockade may exacerbate bronchospasm. Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. Pregnancy and lactation: use only if benefits outweigh risks. Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Labetalol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (e.g., verapamil, diltiazem): risk of severe heart block. - Clonidine withdrawal: may precipitate hypertensive crisis.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may mask hypoglycaemia symptoms. - NSAIDs: can reduce antihypertensive effect. - MAO inhibitors: potential for hypertensive episodes. - Antidepressants (tricyclics): increased risk of cardiac arrhythmias.